Update from the 2013 international neurofibromatosis conference-Reference-Cited by-同舟云学术

Update from the 2013 international neurofibromatosis conference

Published:2014-09-24 Issue:12 Volume:164 Page:2969-2978
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Plotkin Scott R.¹,Albers Anne C.²,Babovic-Vuksanovic Dusica³,Blakeley Jaishri O.⁴,Breakefield Xandra O.⁵,Dunn Courtney M.²,Evans D. Gareth⁶,Fisher Michael J.⁷,Friedman Jan M.⁸,Giovannini Marco⁹,Gutmann David H.²,Kalamarides Michel¹⁰,McClatchey Andrea I.¹¹,Messiaen Ludwine¹²,Morrison Helen¹³,Parkinson David B.¹⁴,Stemmer-Rachamimov Anat O.¹¹,Van Raamsdonk Catherine D.⁸,Riccardi Vincent M.¹⁵,Rosser Tena¹⁶,Schindeler Aaron¹⁷,Smith Miriam J.⁶,Stevenson David A.¹⁸,Ullrich Nicole J.¹⁹,van der Vaart Thijs²⁰,Weiss Brian²¹,Widemann Brigitte C.²²,Zhu Yuan²³,Bakker Annette C.²⁴,Lloyd Alison C.²⁵

Affiliation:

1. Department of Neurology and Cancer Center; Massachusetts General Hospital; Harvard Medical School; Boston Massachusetts

2. Department of Neurology; Washington University School of Medicine; St. Louis Missouri

3. Department of Medical Genetics; Mayo Clinic; Rochester Minnesota

4. Department of Neurology; Johns Hopkins University; Baltimore Maryland

5. Neuroscience Center; Center for Molecular Imaging and Department of Neurology; Massachusetts General Hospital/Harvard Medical School; Boston Massachusetts

6. Center for Genomic Medicine; St Mary's Hospital; Manchester Academic Health Sciences Centre; University of Manchester; Manchester UK

7. Division of Oncology; Children's Hospital of Philadelphia; Philadelphia Pennsylvania

8. Department of Medical Genetics; University of British Columbia; Vancouver Canada

9. Center for Neural Tumor Research; House Research Institute; Los Angeles California

10. Department of Neurosurgery; Hopital Pitié-Salpêtriére; Paris France

11. Department of Pathology; Massachusetts General Hospital/Harvard Medical School; Boston Massachusetts

12. Department of Genetics; University of Alabama at Birmingham; Birmingham Alabama

13. Leibniz Institute for Age Research; Jena Germany

14. Centre for Biomedical Research; University of Plymouth, Peninsula College of Medicine and Dentistry; Plymouth UK

15. The Neurofibromatosis Institute; La Crescenta California

16. Department of Neurology; Children's Hospital, Los Angeles, University of Southern California; Los Angeles California

17. Kids' Research Institute; The Children's Hospital at Westmead; University of Sydney; Westmead Australia

18. Division of Medical Genetics; Department of Pediatrics; University of Utah; Salt Lake City Utah

19. Departments of Neurology and Pediatric Oncology; Boston Children's Hospital; Harvard Medical School; Boston Massachusetts

20. ENCORE - NF1 Center; Erasmus MC Rotterdam The Netherlands

21. Division of Hematology/Oncology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

22. Pediatric Oncology Branch; National Cancer Institute; Bethesda Maryland

23. Gilbert Neurofibromatosis Institute; Children's National Medical Center; Washington District of Columbia

24. Children's Tumor Foundation; New York New York

25. MRC Laboratory for Molecular Cell Biology; University College London; London UK

Funder

National Institutes of Health

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajmg.a.36754/fullpdf

Reference40 articles.

1. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas;Antinheimo;Neurology,2000

2. Multiple orbital neurofibromas, painful peripheral nerve tumors, distinctive face and marfanoid habitus: A new syndrome;Babovic-Vuksanovic;Eur J Hum Genet,2012

3. Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy;Baumer;J Neurol,2013

4. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations;Brastianos;Nat Genet,2013

5. Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis;Burkitt Wright;J Med Genet,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexistence of indural meningioma and schwannoma in different segments of the cervical spine:a case report and literature review;2024-01-22

2. Comparison of the frequency of loss‐of‐function LZTR1 variants between schwannomatosis patients and the general population;Human Mutation;2022-04-14

3. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis—Practice Resource of the National Society of Genetic Counselors;Journal of Genetic Counseling;2020-06-29

4. Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells;The Laryngoscope;2020-05-21

5. Clinical Management of Children and Adolescents with Neurofibromatosis Type 1 Like Phenotypes and Complex Behavioural Manifestations: A Multidisciplinary and Dimensional Approach;Case Reports in Psychiatry;2019-12-31